TT-dependent NGFRp75/TNFR16 cleavage would disrupt neurotrophin dependent proliferation in cancer cells due to receptor shedding, and this may in part contribute to TT having efficiency in melanoma treatment, where four patients reached a complete response [9]. The gene discussed is BDNF; the disease is melanoma.